1.Zhu,Z.,Han,Y.,Gong,M.,Sun,B.,Zhang,R.,andDing,Q. Establishment of replication-competent vesicular stomatitis virus recapitulating SADS-CoV entry.Journal of Virologydoi: 10.1128/jvi.01957-23(2024)
2.Song,J.,Hong,J.,Yang,C.,Zhang,Y.,Li,Z.,He,P., andDing,Q. Recapitulation of the Powassan virus life cycle in cell culture. mBio 15:e03468-23(2024)
3.Ju,X.,Wang,Z.,Wang,P.,Ren,W.,Yu,Y.,Yu,Y.,Yuan,B.,Song,J.,Zhang,X.,Zhang,Y.,Xu,C.,Tian,B.,Shi,Y.,Zhang,R., andDing,Q. SARS-CoV-2 main protease cleaves MAGED2 to antagonize host antiviral defense. mBio14(4):e0137323(2023)
4. Ju, X., Yu, Y., Ren, W., Dong, L., Meng, X., Deng, H., Nan, Y., and Ding, Q.The PRMT5/WDR77 complexrestricts hepatitis E virus replication. PLoS Pathogens 19(6): e1011434 (2023)
5.Ren,W.,Zhang,Y.,Rao,J.,Wang,Z.,Lan,J.,Liu,K.,Zhang,X.,Hu,X.,Yang,C.,Zhong,G.,Zhang,R.,Wang,X.,Shan,C.*, andDing, Q*.Evolution of Immune Evasion and Host Range Expansion by the SARS-CoV-2 B.1.1.529 (Omicron) Variant. mBio14:e00416-23(2023)(*, co-corresponding author)
6. Ren, W., Zhu, Y., Lan, J., Chen, H., Wang, Y., Shi, H., Feng, F., Chen, D., Close, B., Zhao, X., Wu, J., Tian, B., Yuan, Z., Zhou, D., Saeed, M., Wang, X.*, Zhang, R.*, and Ding, Q*. Susceptibilities of Human ACE2 Genetic Variants in Coronavirus Infection. Journal of Virology 96(1): e01492-21 (2022) (*, co-corresponding author)
7. Ren, W., Ju, X., Gong, M., Lan, J., Yu, Y., Long, Q., Kenney, D., O’Connell, A., Zhang, Y., Zhong, J., Zhong, G., Douam, F., Wang, X., Huang, A., Zhang, R., and Ding, Q. Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion. mBio doi: 10.1128/mbio.00099-22 (2022)
8. Gong, M., Yang, Y., Huang, Y., Gan, T., Wu, Y., Gao, H., Li, Q., Nie, J., Huang, W., Wang, Y., Zhang, R., Zhong, J., Deng, F., Rao, Y.*, and Ding Q*. Novel quinolone derivatives targeting human dihydroorotate dehydrogenase suppress Ebola virus infectionin vitro. Antiviral Research 194: 105161 (2021) (*, co-corresponding author)
9. Ren, W., Lan, J., Ju, X., Gong, M., Long, Q., Zhu, Z., Yu, Y., Wu, J., Zhong, J., Zhang, R., Fan, S., Zhong, G., Huang, A., Wang, X.*, and Ding, Q*. Mutation Y453F in the spike protein of SARS-CoV-2 enhances interaction with the mink ACE2 receptor for host adaption. PLoS Pathogens doi: 10.1371/journal.ppat. 1010053 (2021) (*, co-corresponding author)
10. Sun, L., Li, P., Ju, X., Rao, J., Huang, W., Ren, L., Zhang, S., Xiong, T., Xu, K., Zhou, X., Gong, M., Miska, E., Ding, Q.*, Wang, J.*, and Zhang, Q*. In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs. Cell 184: 1-19 (2021) (*, co-corresponding author)
11. Liu, Y., Hu, G., Wang, Y., Ren, W., Zhao, X., Ji, F., Zhu, Y., Feng, F., Gong, M., Ju, X., Zhu, Y., Cai, X., Lan, J., Guo, J., Xie, M., Dong, L., Zhu, Z., Na, J., Wu, J., Lan, X., Xie, Y., Wang, X., Yuan, Z.*, Zhang, R.*, and Ding, Q*. Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2. PNAS 118(12): e2025373118 (2021) (*, co-corresponding author)
12. Ju, X., Zhu, Y., Wang, Y., Li, J., Zhang J., Gong, M., Ren, W., Li, S., Zhong, J., Zhang, Q., Zhang, R., and Ding, Q. A novel cell culture system modeling the SARS-CoV-2 life cycle. PLoS Pathogens doi: 10.1101/2020.12.13.422469 (2021)
13. Ren, W., Hu, G., Zhao, X., Wang, Y., Shi, H., Lan, J., Zhu, Y., Wu, J., Kenney, D., Florian, D., Tong, Y., Zhong, J., Xie, Y., Wang, X., Yuan, Z., Zhou, D., Zhang, R.*, and Ding, Q.*, Comparative analysis reveals the species-specific genetic determinants of ACE2 required for SARS-CoV-2 entry. PLoS Pathogens doi: 10.1101/2020.09.20.297242 (2021) (*, co-corresponding author)
14. Ju, X., Xiang, G., Gong, M., Yang, R., Qin, J., Li, Y., Nan, Y., Yang, Y., Zhang, Q., and Ding, Q. Indentification of functional cis-acting RNA elements in the hepatitis E virus genome required for viral replication. PLoS Pathogens 16: e1008488 (2020)
15. Ju, X., and Ding, Q. Hepatitis E Virus Assembly and Release. Viruses 11: 539 (2019)
